Clinical trial
Development of a Predictive Model of Liver Complications Emergence in Patients With Advanced Fibrosis Who Achieve Sustained Virological Response With Direct-acting Antivirals-based Therapy
NCT04460157 is registered in ClinicalTrials.gov with Hospital Universitario de Valme as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Predictive Model of Liver Complications Emergence in Patients With Advanced Fibrosis Who Achieve Sustained Virological Response With Direct-acting Antivirals-based Therapy
- Lead sponsor
- Hospital Universitario de Valme
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2011
- Completion date
- December 31, 2021
- Enrollment
- 1,035 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
direct-acting antivirals, hepatic decompensation, hepatitis c, chronic, hepatocellular carcinoma, sustained virological response